Company Data
Scinai Immunotherapeutics Ltd.
Ticker
SCNI
Current Price
$0.555 -7.5%
Market Cap
$2.0M
Price Target
Refer to Report
Volume
69.4K
52wk Range
$0.55 - $6.18
Overview
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.